FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for GATTEX (teduglutide) by Takeda Pharmaceuticals America, expanding its labeling for short bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• GATTEX (teduglutide)

Snippet

SUPPL AP for GATTEX (TEDUGLUTIDE)